Manisha Bansal | Medicinal Research | Best Researcher Award

Published on by Academic Awards

Assist. Prof. Dr. Manisha Bansal | Medicinal Research | Best Researcher Award

Punjabi University Patiala | India

Assist. Prof. Dr. Manisha Bansal serves as Assistant Professor (Stage III) in the Department of Chemistry, Punjabi University, Patiala, India. She holds a Ph.D. in Synthetic and Medicinal Chemistry with a thesis on antihypertensive agents and has over 17 years of teaching and 15 years of research experience. Her expertise lies in synthetic organic chemistry, medicinal chemistry, and photochemistry, with extensive work in drug design, molecular modeling, and bioactive compound synthesis. Assist. Prof. Dr. Manisha Bansal has published 20 research papers, accumulating 92 citations and an h-index of 6, with publications in reputed journals like Molecular Diversity, Bioorganic Chemistry, and Journal of Biomolecular Structure and Dynamics. She has guided multiple M.Phil. and Ph.D. scholars, presented at numerous national and international conferences, and contributed as a reviewer for leading journals. Her current research explores multi-targeted drug design against inflammatory, microbial, and cancer pathways.

Profile: Scopus | Orcid | Google Scholar

Featured Publications

1. Jain, R., & Bansal, M. (1995). A fascile synthesis and central nervous system activities of fluorine containing spiro-[3H-indole-3, 4′(4H)-pyran]-2 (1H)-ones. Pharmazie, 50(3), 224–225. (Cited by 18)

2. Kaur, G., Kaur, M., Sharad, L., & Bansal, M. (2020). Theoretical molecular predictions and antimicrobial activities of newly synthesized molecular hybrids of norfloxacin and ciprofloxacin. Journal of Heterocyclic Chemistry, 57(1), 225–237. (Cited by 13)

3. Bansal, M., & Kaur, R. (2015). Electromeric effect of substitution at 6th position in 2-(Furan-2-yl)-3-hydroxy-4H-chromen-4-one (FHC) on the absorption and emission spectra. Journal of Chemical Sciences, 127(3), 405–412. (Cited by 13)

4. Kaur, M., Rehman, H. M., Kaur, G., Kaur, A., & Bansal, M. (2023). Switching of newly synthesized linker-based derivatives of non-steroidal anti-inflammatory drugs toward anti-inflammatory and anticancer activity. Bioorganic Chemistry, 133, 106406. (Cited by 12)

5. Kaur, G., Kaur, M., & Bansal, M. (2021). New insights of structural activity relationship of curcumin and correlating their efficacy in anticancer studies with some other similar molecules. American Journal of Cancer Research, 11(8), 3755–3769. (Cited by 9)

 

Jing Nie | Medicinal Chemistry | Best Researcher Award

Published on by Academic Awards

Ms. Jing Nie | Medicinal Chemistry | Best Researcher Award

Ms. Jing Nie | Shandong Second Provincial General Hospital | China

Ms. Jing Nie serves as the Head of Scientific Research in the Department of Pharmacy at Shandong Second Provincial General Hospital and holds the position of Associate Chief Pharmacist. She actively contributes to the advancement of pharmaceutical sciences through her leadership roles in various professional committees, including the Shandong Provincial Hospital Association’s Digital and Intelligent Pharmacy Committee, the Pediatric Rational Drug Use Committee of the Shandong Pharmacists Association, and the Otolaryngology Pharmacy Committee of the Shandong Pharmaceutical Society. She is also a core member of the Rheumatology Committee of the Jinan Association of Integrated Traditional Chinese and Western Medicine, the Antitumor Drug Committee of the Shandong Pharmaceutical Society, the Tumor Pharmacy Branch of the Shandong Anti-Cancer Association, and the Internet Plus Pharmacy Services Committee. Her research focuses on hospital pharmacy, artificial intelligence, pharmacoeconomics, and antitumor drug development. She has published extensively, secured patents, developed software, and led multiple provincial and collaborative projects while contributing to numerous national-level studies.

Publication Profile

Scopus

Education

Ms. Jing Nie earned her doctoral degree in pharmacy, equipping her with a strong academic foundation to contribute to both scientific research and clinical pharmacy practice. Her education combined rigorous theoretical learning with extensive research experience, allowing her to specialize in the integration of hospital pharmacy with advanced technologies such as artificial intelligence and pharmacoeconomics. During her doctoral training, she focused on evidence-based approaches to optimize drug therapy and explored the mechanisms and applications of antitumor drugs. Her academic journey not only strengthened her technical expertise but also instilled in her a deep commitment to innovation, patient safety, and rational drug use. She has built upon her formal education through continuous professional development, actively engaging with academic societies, conferences, and specialized committees that broaden her knowledge and keep her at the forefront of evolving pharmaceutical sciences. Her educational background remains the cornerstone of her contributions to research and practice.

Experience

Ms. Jing Nie has extensive professional experience as the Head of Scientific Research in the Department of Pharmacy at Shandong Second Provincial General Hospital, where she also serves as Associate Chief Pharmacist. Her experience includes leadership and active participation in multiple prestigious committees, such as those dedicated to digital pharmacy, rational pediatric drug use, otolaryngology pharmacy, rheumatology, and oncology. She has played a key role in advancing pharmaceutical sciences by bridging hospital pharmacy with innovative fields like artificial intelligence and pharmacoeconomics. Her experience is further reflected in her strong publication record, where she has authored and co-authored more than twenty scientific papers, many in high-impact journals. She has successfully applied her expertise to provincial-level projects, cross-disciplinary collaborations, and has contributed significantly to national-level studies. In addition, her practical work includes obtaining multiple patents and software copyrights, reinforcing her ability to translate scientific innovation into practical applications that benefit patients and the healthcare system.

Research Focus

Ms. Jing Nie’s research focus lies at the intersection of pharmaceutical sciences, oncology, and innovative therapeutic strategies. Her work on the advances of HDAC dual inhibitors in breast cancer treatment highlights her commitment to exploring novel drug mechanisms and targeted therapies in oncology. By investigating epigenetic regulation through HDAC inhibition, she contributes to the development of more effective treatments for breast cancer patients, bridging basic research with clinical applications. Beyond oncology, her broader focus includes hospital pharmacy, pharmacoeconomics, artificial intelligence in drug management, and rational drug use. This multidisciplinary approach allows her to integrate clinical practice with cutting-edge research, addressing both the economic and therapeutic aspects of patient care. Her emphasis on anti-tumor drug development, combined with her role in scientific committees and leadership positions, reflects a holistic vision of improving healthcare outcomes through innovation, collaboration, and translational research. Ms. Nie’s focus is well aligned with advancing precision medicine and modern pharmacy.

Publication Top Notes

Advances of HDAC dual inhibitors in breast cancer treatment

Conclusion

Ms. Jing Nie is highly suitable for the Research for Best Researcher Award, given her impactful contributions to pharmaceutical sciences, leadership roles, and innovation in anti-tumor drug research and artificial intelligence. With strategic international engagement and clinical translation of her work, she has the potential to become a globally recognized leader in hospital pharmacy research.

Neda Shakour | Medicinal chemistry | Best Researcher Award

Published on by Academic Awards

Dr. Neda Shakour | Medicinal chemistry | Best Researcher Award

Dr. Neda Shakour, Mashhad University of Medical Science, Iran

Dr. Neda Shakour is a distinguished medicinal chemist at Mashhad University of Medical Sciences, specializing in drug design for diabetes treatment. With a Ph.D. in Medicinal Chemistry, her research focuses on thiazolidinediones and in silico drug discovery. She has extensive teaching experience and has contributed to regulatory work at the Food and Drug Administration of Mashhad. Recognized with numerous awards and research grants, Dr. Shakour has published extensively on cancer therapies, metabolic diseases, and nanomedicine, making significant advancements in medical science. 🏆🔬

Publication Profile

Google Scholar

🎓 Education

Dr. Neda Shakour earned her Ph.D. in Medicinal Chemistry from Mashhad University of Medical Sciences, focusing on designing and synthesizing novel thiazolidinediones for diabetes treatment. She completed her M.Sc. in Organic Chemistry at the University of Zanjan, where she specialized in nanoscale compound synthesis. Her academic journey began with a B.Sc. in Chemistry from Islamic Azad University of Shahreza. Throughout her studies, Dr. Shakour demonstrated exceptional research capabilities, gaining recognition for her contributions to medicinal chemistry. 📘🧪

👩‍🏫 Experience

Dr. Neda Shakour has over a decade of teaching experience at institutions like the Non-Profit Institute of the Role of the World in Isfahan, Shahreza University, and Borujen University. From 2021 to 2023, she worked as a postdoctoral researcher at Mashhad University of Medical Sciences, specializing in drug discovery. Currently, she is actively contributing to the Food and Drug Administration of Mashhad, where she applies her expertise in medicinal chemistry to enhance drug regulation and healthcare policies. 📚🔎

🏅 Awards and Honors

Dr. Neda Shakour was awarded the Level 3 Research and Innovation Credit by the National Elite Foundation in 2010. In 2024-2025, she secured prestigious research grants for two groundbreaking projects on non-peptide GLP-1R natural agonists and kidney failure treatments. Her consistent recognition for research excellence underscores her impact in drug discovery and diabetes management. With her dedication to innovation, Dr. Shakour remains a leader in medicinal chemistry research. 🥇🔬

🔍 Research Focus

Dr. Neda Shakour’s research spans the design, synthesis, and biological evaluation of organic compounds, particularly thiazolidinediones for diabetes treatment. She specializes in in silico drug discovery, biomimetic synthesis, and the development of targeted therapies for metabolic diseases. Her work also addresses cancer treatments and fibrosis management, demonstrating a commitment to improving patient outcomes. Dr. Shakour’s research significantly advances therapeutic innovation in pharmaceutical science. 💡🧪

Publication Top Notes

  • 📖 The natural phenolic compounds as modulators of NADPH oxidases in hypertension – Phytomedicine 55, 200-213 – Cited by: 176 – Year: 2019 🌿

  • 📖 Statins and C-reactive protein: in silico evidence on direct interaction – Archives of Medical Science 16 (6), 1432-1439 – Cited by: 60 – Year: 2020 💊

  • 📖 Ethnobotany, Phytochemistry and Pharmacological Features of Centella asiatica: A Comprehensive Review – Pharmacological Properties of Plant-Derived Natural Products – Cited by: 35 – Year: 2021 🌱

  • 📖 Docetaxel encapsulation in nanoscale assembly micelles for targeted metastatic breast cancer therapy – International Journal of Pharmaceutics 605, 120822 – Cited by: 31 – Year: 2021 🧬

  • 📖 In silico evidence of direct interaction between statins and β‐amyloid – Journal of Cellular Biochemistry 120 (3), 4710-4715 – Cited by: 23 – Year: 2019 🧠

  • 📖 Cellulose-based nanofibril composite materials for bacterial infection control – Frontiers in Bioengineering and Biotechnology 9, 732461 – Cited by: 22 – Year: 2021 🦠

  • 📖 Design, synthesis and biological evaluation of novel thiazolidinediones as antidiabetic agents – Bioorganic Chemistry 115, 105162 – Cited by: 20 – Year: 2021 🍎

  • 📖 Data mining approaches to explore the association between type 2 diabetes mellitus with SARS-CoV-2 – BMC Pulmonary Medicine 23 (1), 1-14 – Cited by: 19 – Year: 2023 🩸

  • 📖 Candesartan inhibits tumor growth and fibrosis in colorectal cancer – Excli Journal 20, 863 – Cited by: 17 – Year: 2021 🧑‍⚕️

  • 📖 Dual targeting of TGF-β and PD-L1 in colorectal carcinoma – Life Sciences 328, 121865 – Cited by: 13 – Year: 2023 🧫

 

 

Pingping Cai | Medicine | Best Researcher Award

Published on by Academic Awards

Dr. Pingping Cai | Medicine | Best Researcher Award

Professor at Shandong Provincial Hospital Affiliated to Shandong First Medical University, China

Prof. Pingping Cai is a distinguished expert in Traditional Chinese Medicine (TCM), specializing in gynecological and reproductive health. She is a Professor at the Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, China. With a Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine, her research focuses on TCM treatments for infertility, gynecological tumors, pregnancy disorders, breast diseases, and reproductive endocrine diseases. Prof. Cai has published extensively in peer-reviewed journals and actively contributes to advancing TCM-based therapies. Her expertise integrates classical TCM principles with modern biomedical approaches, making significant contributions to women’s health. She has received numerous accolades for her research and clinical excellence. 🌿🏥📚

Publication Top Notes

scopus

🎓 Education

Prof. Pingping Cai earned her Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine (2003-2006), where she focused on integrating classical Chinese medical theories with modern gynecological treatments. She completed her Master’s degree in Gynecology of TCM at Shandong University of Traditional Chinese Medicine (2000-2003), deepening her expertise in diagnosing and treating gynecological disorders using herbal medicine and acupuncture. Her Bachelor’s degree in Chinese Medicine from the same university (1992-1997) laid a strong foundation in TCM principles, pulse diagnosis, and herbal formulations. Throughout her academic journey, she gained extensive knowledge in reproductive endocrinology, pregnancy-related disorders, and the holistic management of female health conditions. Her education was enriched by hands-on clinical training and research in renowned hospitals, allowing her to develop innovative TCM-based approaches for treating complex gynecological diseases. Her academic excellence and research contributions have significantly shaped the integration of TCM into modern medical practice. 🎓📖🌱

💼 Experience

Since 2006, Prof. Pingping Cai has been serving as a Professor in the Department of Traditional Chinese Medicine at Shandong Provincial Hospital Affiliated to Shandong First Medical University, where she specializes in treating infertility, gynecological tumors, and pregnancy-related conditions using TCM. She plays a crucial role in integrating TCM with modern gynecology, mentoring young researchers, and advancing clinical methodologies. Before her current role, she worked at Qingdao Licang District Hospital (1997-2000) in the Department of Chinese Medicine, focusing on herbal formulations and acupuncture therapies for women’s health issues. Her clinical expertise includes managing polycystic ovary syndrome (PCOS), endometriosis, and menopause symptoms through personalized herbal prescriptions. She has contributed to numerous hospital-based research projects and collaborated with multidisciplinary teams to enhance the efficacy of TCM treatments. Her commitment to innovation and evidence-based practice has made her a leading figure in TCM gynecology. 🏥🌿👩‍⚕️

🏅 Awards & Honors

Prof. Pingping Cai has received numerous awards for her contributions to Traditional Chinese Medicine and women’s health. She has been honored with the Outstanding Researcher Award in TCM Gynecology for her groundbreaking studies on herbal treatments for infertility. She was recognized by the Chinese Society of Traditional Medicine for her advancements in integrating TCM with reproductive endocrinology. Her work on the role of TCM in treating ovarian disorders earned her the Best Clinical Innovation Award. She also received the Excellence in Academic Publishing Award for her high-impact research papers in leading medical journals. Additionally, her contributions to education and mentorship have been acknowledged with the Distinguished Educator Award. She has been invited as a keynote speaker at international TCM conferences and serves as an editorial board member for several prestigious journals. Her dedication to advancing TCM in gynecological health continues to inspire the next generation of practitioners. 🏆📜🌏

🔬 Research Focus

Prof. Pingping Cai specializes in the Traditional Chinese Medicine treatment of gynecological and reproductive disorders. Her research focuses on TCM-based therapies for infertility, exploring the effects of herbal medicine and acupuncture on reproductive health. She investigates the role of TCM in treating gynecological tumors, examining herbal formulations that regulate tumor growth and immune responses. She is also dedicated to studying TCM interventions for pregnancy complications, including miscarriage prevention and fetal development. Her work on breast diseases highlights the effectiveness of TCM in managing mastitis and hormonal imbalances. Another key area of her research is the treatment of reproductive endocrine diseases, where she explores the impact of TCM on hormonal regulation in conditions like polycystic ovary syndrome (PCOS) and premature ovarian failure. Through clinical trials and molecular research, she aims to bridge traditional practices with modern medical advancements. Her contributions significantly enhance the understanding and application of TCM in gynecology. 🌿🩺📊

 

Publication Top Notes

  • Xu Y, Li Y, Zhang J, Cai P. “Hua Yu Xiao Zheng decoction induces ectopic endometrial stromal cell senescence via inhibiting the PI3K/AKT signaling.” Tissue Cell. 2025 Apr;93:102763.

    scholar.google.com

  • Shao W, Lin Z, Xiahou Z, Zhao F, Xu J, Liu X, Cai P. “Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer.” Front Immunol. 2024 Jul 29;15:1438198.

    scholar.google.com

  • Wang Y, Cai P, Qi F. “Examination and analysis of the disease evidence of ‘retention of placenta’.” China Journal of Basic Medicine in Traditional Chinese Medicine. 2024;30(10):1633-1637.

    scholar.google.com

  • Wang Z, Cai P. “Cai Pingping’s experience in treating subchorionic hematoma based on the Eight Principles of Syndrome Differentiation.” Shanghai Journal of Traditional Chinese Medicine. 2024;58(04):54-57.

    scholar.google.com

  • Yan R, He J, Xue Y, Wang Y, Dong R, Cai P. “Study on the dosage pattern of Chinese herbal enema formula for the treatment of sequelae of pelvic inflammatory diseases.” Chinese Traditional Patent Medicine. 2024;46(10):3492-3496.

    scholar.google.com

  • Su N, Cai P, Dou Z, Yin X, Xu H, He J, Li Z, Li C. “Brain nuclei and neural circuits in neuropathic pain and brain modulation mechanisms of acupuncture: a review on animal-based experimental research.” Front Neurosci. 2023 Aug 30;17:1243231.

    scholar.google.com

  • Wang Y, Qiu H, Yan R, Jing W, Li J, Cai P. “Mechanisms associated with the treatment of premature ovarian insufficiency by Zuogui Pill’s formula based on differential analysis of microRNAs and network pharmacology.” Chinese Archives of Traditional Chinese Medicine. 2023;41(04):81-86+269-273.

    scholar.google.com

  • Wang Y, Yan R, Jing W, Cai P. “Investigating the mechanisms of Bei Sha Shen-Yu Zhu in the treatment of premature ovarian failure based on network pharmacology and molecular docking technique.” Traditional Chinese Drug Research and Clinical Pharmacology. 2022;33(05):645-654.

    scholar.google.com

  • Wang Z, Qi F, Cui Y, Zhao L, Sun X, Tang W, Cai P. “An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics.” Biosci Trends. 2018;12(3):220-239.

    scholar.google.com

  • Cai P, Liu X, Xu Y, Qi F, Si G. “Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.” Biosci Trends. 2017;11(6):640-650.

    scholar.google.com

 

 

 

Young Jun Kim | Pharmaceutical Science | Best Researcher Award

Published on by Academic Awards

Prof. Dr. Young Jun Kim | Pharmaceutical Science | Best Researcher Award

professor, Korea university, South Korea

📌 Prof. Dr. Young Jun Kim is a distinguished food scientist 🥼 specializing in functional food, biotechnology, and nutrition. He is a Professor at Korea University (2013–present) and serves as Dean of the Dept. of Food and Biotechnology. He earned his Ph.D. in Food Science from Cornell University (2001), focusing on conjugated linoleic acids (CLA) in dairy products. He has held key positions, including Business Director at Caregen Co., Ltd. and Executive Vice Chairman of the Dietary Supplement Review Board. His research spans cholinergic compounds, antioxidants, and bioflocculants. Recognized with multiple awards, he continues to shape food science and regulatory policies. 🏆

Publication Profile

Scopus

🎓 Academic Background

Prof. Dr. Young Jun Kim holds a Ph.D. in Food Science 🥼 from Cornell University (2001), where his research focused on the production of conjugated linoleic acids (CLA) by rumen bacteria 🦠 and their enhancement in dairy products 🥛. He earned his M.S. in Food Science and Technology from Korea University (1996), investigating bioflocculant production by Corynebacterium sp. K-199 🧪. His academic journey began with a B.S. in Food Biotechnology from Korea University (1994), where he developed expertise in biotechnological applications in food science 🍽️. His research has significantly contributed to nutrition and functional food innovations. 🚀

🔬 Research Experience

Prof. Dr. Young Jun Kim has an extensive research background in food science, biotechnology, and functional compounds 🧪. As a Visiting Professor at the University of Saskatchewan (2023–2024), he explored cholinergic compounds for health, muscle strength improvement 💪, and α-GPC functionality. His postdoctoral research at Cornell University (2002–2004) involved cellulosome construction and polyphenol recovery from apple peel 🍏. He also worked on Arg-CLA’s antioxidant and anticancer properties at Seoul National University (2002). Earlier, at Boyce Thompson Institute, he contributed to edible vaccine development 🏥. His graduate research at Cornell and Korea University focused on CLA-enriched dairy 🥛 and bioflocculants for wastewater treatment. 🌿

🏆 Honors and Awards

Prof. Dr. Young Jun Kim has received numerous prestigious awards for his contributions to food science and nutrition 🧪. He was honored with the Minister of Science and ICT Commendation (2023) for fulfilling national R&D missions and received the Best Paper Award at the Korean Society of Food and Nutrition Science Conference (2023) 📜. His contributions to public health and nutrition earned him recognition from the U.S. Secretary of Health and Human Services (2021) 🇺🇸. He has also been listed in Marquis Who’s Who in Medicine and Healthcare (2009–2010) and won multiple research and lecture awards from Cornell University, Korea University, and IFT 🎓.

🔬 Research Focus

Prof. Dr. Y.J. Kim specializes in food science, nutrition, and bioactive compounds 🥗🧪. His research explores functional foods, fermentation, antioxidants, and muscle atrophy prevention. Recent studies focus on Arriheuk wheat sprout extract for muscle health, α-Glycerylphosphorylcholine production in fermented foods, and anti-inflammatory effects of barley sprout fermentation 🌱. Additionally, he investigates sleep-enhancing compounds, food sensory optimization, and bioactive extracts from plants 🍏🌿. His expertise extends to flavor chemistry, browning prevention in fresh produce, and interleukin inhibition for health applications 🏥. His work significantly contributes to nutritional science and functional food development.

Publication Top Notes

  • Suppressive Effects of Arriheuk Wheat Sprout Extract on Muscle Atrophy in Dexamethasone-Induced C2C12 Myotubes and a Mouse Model
    Year: 2024 🧬
  • Production of α-Glycerylphosphorylcholine in Fermented Roots, Tubers, and Fruits
    Year: 2024 🍠
  • UP165, Standardized Corn Leaf Extract and its Active Component 6-Methoxybenzoxazolinone Induce Non-Rapid Eye Movement Sleep through Melatonergic and GABAergic Mechanisms
    Year: 2024 🌿
  • Characterization of Taste and Aroma Profile in Pomegranate (Punica Granatum L.) Seed Oil Using Electronic Sensors, GC-MS/Olfactometry
    Year: 2024 🍎
  • Validation of Optimization Methods for Sensory Characteristics Using Rate-All-That-Apply and Intensity Scales: A Case Study of Apple Juice
    Year: 2024 🍏
  • Antioxidant Activity of Extracts of Balloon Flower Root (Platycodon Grandiflorum), Japanese Apricot (Prunus Mume), and Grape (Vitis Vinifera) and Their Effects on Beef Jerky Quality
    Year: 2024 🍇
  • Prediction Model of Browning Inhibitor Concentration and its Optimal Composition for Mass Processing of Ready-to-Eat Fresh-Cut ‘Fuji’ Apple (Malus Domestica Borkh.) Strains
    Year: 2024 🍏
  • Identification of Interleukin (IL)-33 Inhibitory Constituents from Canavalia Gladiata Pods
    Cited by: 0
    Year: 2024 🌿
  • The Inhalation Effect of Osmanthus Fragrans var. Aurantiacus on Physiological Parameters in Chronically Stressed Rats
    Cited by: 1
    Year: 2024 🌸
  • Anti-Inflammatory Effects of Barley Sprout Fermented by Lactic Acid Bacteria in RAW264.7 Macrophages and Caco-2 Cells
    Cited by: 3
    Year: 2024 🌾

Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Published on by Academic Awards

Prof. Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award

Prof. Fatmah Alasmary, Saudi Food and Drug Authority, Saudi Arabia

Professor at King Saud University, specializing in organic chemistry. Dr. Alasmary has extensive experience in academia and leadership, with a PhD from the University of Bradford. Currently, she serves as Director of the Drug Lab at the Saudi Food and Drug Authority. Her research interests include antimicrobial agents and nanomaterials. Dr. Alasmary has mentored numerous students and has held key roles in various scientific committees. She is a member of the Saudi Chemical Association, the Royal Society of Chemistry, and the American Chemical Society. 🧑‍🔬👩‍🏫🔬

Publication Profile

Google Scholar

Work Experience 🌍💼

Prof. Fatmahalasmary is a distinguished academic and professional, currently serving as the Director of Drug Lab at Saudi Food and Drug Authority, Riyadh. She oversees quality control, safety standards, and international accreditation efforts for medicines and cosmetics. As Chief of Senior Expert International Communication, she leads food standards initiatives for Saudi Arabia, managing ISO committees and Codex committees. Previously, she was Vice Chairman at King Saud University’s Chemistry Department, coordinating research, teaching, and international collaborations. Prof. Fatmahalasmary’s leadership spans teaching, curriculum development, and guiding postgraduate research, exemplifying excellence in both academic and professional spheres. 📚🌐👩‍🔬

 

Qualifications 🎓🌟

Prof. Fatmahalasmary holds a PhD in Chemistry from the University of Bradford, England (2013), where her thesis focused on the synthesis and evaluation of benzimidazole derivatives as potential antimicrobial agents. She earned a Master of Science in Chemistry from King Saud University, KSA (2008), with a thesis on the synthesis and study of quinoxaline derivatives. Additionally, she completed her Bachelor of Science in Chemistry at King Saud University, KSA (2001), graduating with honors. Her academic journey highlights a strong foundation in chemistry and a commitment to research excellence. 🧪📘👩‍🔬

 

Additional Experience 🌍🔬

Prof. Fatmahalasmary has actively participated in over 22 workshops focused on management, planning, and quality development. She is a member of several prestigious associations, including the Saudi Chemical Association, Royal Society of Chemistry, and American Chemical Society. Her roles have included coordinating committees at King Saud University (KSU), such as the Development and Quality Committee and Labs Committee. Prof. Fatmahalasmary has also been involved in thesis defenses, scientific symposia, and national exhibitions. She holds patents for innovative extracts and is certified in ISO 9001:2015 and as a Certified Innovation Professional. 📚💡📈

 

Research Focus

Prof. Fatmah Ali S Alasmary’s research spans various fields, including antimicrobial agents 🦠, biological chemistry 🧬, and medicinal chemistry 💊. She has contributed significantly to the development of benzimidazole derivatives as potential antimicrobial agents, as well as carbonic anhydrase inhibitors targeting various pathogens. Her work also delves into perovskite materials 🏗️, photocatalysis ⚛️, and nanomaterials 🧪 with applications in sensing and biomedical fields. Prof. Alasmary has been actively involved in computational studies of drug design 💻, enzyme inhibition 🧪, and therapeutic applications for diseases like malaria and cancer.

 

Publication Top Notes  

  • Tin versus lead redox chemistry modulates charge trapping and self-doping in tin/lead iodide perovskites (186 citations, 2020) 🔋
  • Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents (140 citations, 2015) 💊
  • Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates (41 citations, 2017) 🦠
  • Direct Access to α‐Aminosilanes Enabled by Visible‐Light‐Mediated Multicomponent Radical Cross‐Coupling (36 citations, 2021) 💡
  • Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3 H)-ones as … (35 citations, 2015) 🔬
  • Analysis of Alpina officinarum Hance, chemically and biologically (30 citations, 2019) 🌿
  • Combined computational and experimental investigation on the nature of hydrated iodoplumbate complexes: Insights into the dual role of water in perovskite precursor solutions (28 citations, 2020) 💧
  • The first activation studies of the η-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids (28 citations, 2018) 🦠
  • New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase (28 citations, 2017) 🧪
  • Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach (27 citations, 2021) 🦠

 

Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Published on by Academic Awards

Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Assist Prof Dr Maryam Tabarzad, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Iran

Based on Dr. Maryam Tabarzad’s profile, she appears to be a strong candidate for the Best Researcher Award due to several key factors:

Publication profile

google scholar

Educational Background

  • MSc in E-learning in Medical Education (2023): Focused on enhancing lab skills through augmented reality in pharmacy students.
  • PhD in Pharmaceutical Biotechnology (2014): Specialized in DNA aptamers against Coagulation Factor VIII.
  • Pharm.D. (2007): Conducted research on bis(4-nitroaryl-1,4-Dihydropyridine) with pharmacological evaluations.

Professional Experience

  • Assistant Professor: Protein Technology Research Center, Shahid Beheshti University of Medical Science (2014-present).
  • Vice-Chancellor of Research Affairs: Protein Technology Research Center (2018-present).
  • Editorial Roles: Managing Editor for Trends in Peptide and Protein Sciences, Associate Editor for Iranian Journal of Pharmaceutical Research, and Editorial member for Future Natural Products.

Notable Publications

  1. Fathi et al. (2024): Investigated antimicrobial peptides for wound healing, published in Burns (Q2, IF: 3.2).
  2. Fathi et al. (2024): Explored structural features of antimicrobial peptides in Bioorganic Chemistry (Q1, IF: 5.1).
  3. Yazdanicherati et al. (2024): Studied the effect of antimicrobial peptides on gold nanoparticles, published in Modares Journal of Biotechnology.

Teaching Experience

  • Extensive teaching roles in pharmaceutical and medical biotechnology across various institutions, including University of Science and Culture, Gilan University of Medical Sciences, and Shahid Beheshti University of Medical Sciences.

Thesis Supervision

  • Supervised multiple Ph.D. and MSc theses in areas such as biosensors, peptide-nanomolecule interactions, and cancer research.

Conclusion

Dr. Maryam Tabarzad’s impressive academic credentials, significant contributions to pharmaceutical biotechnology, influential editorial roles, and robust teaching and supervisory experience make her a highly suitable candidate for the Best Researcher Award. Her research, particularly in the design and development of antimicrobial peptides and aptamers, along with her leadership in research and education, underscores her excellence in the field.

Publication top notes

Therapeutic applications of nucleic acid aptamers in microbial infections

Aptamers as smart ligands for nano-carriers targeting

Anti-inflammatory activity of bioactive compounds from microalgae and cyanobacteria by focusing on the mechanisms of action

Simultaneous detection of bovine and porcine DNA in pharmaceutical gelatin capsules by duplex PCR assay for Halal authentication

Silymarin antiproliferative and apoptotic effects: insights into its clinical impact in various types of cancer

Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers

Anti-cancer drug delivery using carbohydrate-based polymers

Trends in the design and development of specific aptamers against peptides and proteins

Peptide dendrimers as valuable biomaterials in medical sciences

Marzieh Rashedinia | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Academic Awards

Marzieh Rashedinia | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assoc Prof Dr Marzieh Rashedinia, Shiraz university of medical sciences, Iran

Based on the provided information, Assoc. Prof. Dr. Marzieh Rashedinia appears to be a strong candidate for the Best Researcher Award. Here’s a summary of her qualifications and contributions:

Publication profile

google scholar

Education

  • Ph.D. in Toxicology (2013), School of Pharmacy, Mashhad University of Medical Sciences, Iran.
  • M.Sc. in Toxicology (2009), School of Pharmacy, Shiraz University of Medical Sciences, Iran.
  • B.Sc. in Cell and Molecular Biology (2005), School of Sciences, Shiraz University, Iran.

Research Focus

  • Ph.D. Thesis: Evaluation of neuroprotective effects of Crocin on Acrolein-induced neurotoxicity in rats.
  • M.Sc. Thesis: The effect of ATP supplier compounds on Zinc phosphide toxicity in HepG2 Cells.

Research Techniques and Experiences

  • Cell culture, Toxicology screening tests, Animal behavior testing, Western blotting, Proteomics, Real-Time PCR, Immunoprecipitation, HPLC, In vivo and in vitro toxicity testing, Food contaminant analysis, Cell and molecular mechanisms of toxicity.

Notable Publications

  • “Silymarin: A promising pharmacological agent for treatment of diseases” – Iranian Journal of Basic Medical Sciences, 2011.
  • “Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin” – Toxicology and Industrial Health, 2015.
  • “Effects of sodium benzoate on learning, memory, and oxidative stress in mice” – Journal of Biochemical and Molecular Toxicology, 2018.
  • “Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis” – Human & Experimental Toxicology, 2016.

Abstracts and Congress Presentations

  • Syringic acid effects on oxidative stress in diabetic rats – 3rd World Congress and Expo on Traditional and Alternative Medicine, Berlin, 2019.
  • Syringic acid for renal oxidative stress management – 9th World Congress on Targeting Mitochondria, Berlin, 2018.
  • Glycyrrhizic acid modulates aluminium-induced oxidative stress – 6th National Congress on Medical Plants, Tehran, 2017.

Summary

Assoc. Prof. Dr. Marzieh Rashedinia has made significant contributions to the field of toxicology through her research on neuroprotection, oxidative stress, and food contaminants. Her extensive experience with advanced research techniques and impactful publications underlines her suitability for the Best Researcher Award.

Publication top notes

“Silymarin”, a promising pharmacological agent for treatment of diseases

Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin

Effects of sodium benzoate, a commonly used food preservative, on learning, memory, and oxidative stress in brain of mice

Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis

Antioxidant activity of Pistacia vera fruits, leaves and gum extracts

Design and development of vitamin C-encapsulated proliposome with improved in-vitro and ex-vivo antioxidant efficacy

Vortex-assisted dispersive liquid-liquid microextraction based on hydrophobic deep eutectic solvent for the simultaneous identification of eight synthetic dyes in jellies and …

Neuroprotective effect of syringic acid by modulation of oxidative stress and mitochondrial mass in diabetic rats

Ellagic acid improves muscle dysfunction in cuprizone-induced demyelinated mice via mitochondrial Sirt3 regulation

Effect of sodium benzoate on liver and kidney lipid peroxidation and antioxidant enzymes in mice

Sihe Zhang | Pharmacology | Best Researcher Award

Published on by Academic Awards

Prof Sihe Zhang | Pharmacology | Best Researcher Award

Professor at  Nankai University, China

Si-he Zhang is a distinguished cell biologist and professor at Nankai University, China. He earned his PhD in Cell Biology from the Fourth Military Medical University and has held various academic positions including Associate Professor at Lund University Hospital, Sweden. His research focuses on cancer biology, particularly in developing targeted therapies using antibodies and nanoparticle-based drug delivery systems. Zhang has authored numerous influential publications and holds several key patents in the field. He has received prestigious awards, including the Chinese Outstanding Patented Invention Gold Award and the National Prize for Progress in Science & Technology. Zhang also serves on several scholarly committees and as a consultant for leading biopharmaceutical companies in China.

Profile

Scopus

Education:

  • PhD in Cell Biology, Fourth Military Medical University, China, 2001-2004
  • M.A. in Genetics, Jinlin University, China, 1996-1998
  • B.S. in Genetics, Northwest A&F University, China, 1991-1995

Positions Held:

  • Tenured Full Professor, Nankai University, China (2020-present)
  • Tenured Associate Professor, Nankai University, China (2012-2019)
  • Postdoctoral Scientist, Lund University Hospital, Sweden (2006-2009)
  • Associate Professor, Fourth Military Medical University, China (2005-2011)
  • Lecturer, Fourth Military Medical University, China (2000-2005)
  • Teaching Assistant, Fourth Military Medical University, China (1998-2000)

Major Awards:

  • Gold Award for Chinese Outstanding Patented Invention, WIPO-SIPO (2010)
  • National Prize for Progress in Science & Technology, China (2005)

Citations:

  • Citations: 948
  • Documents Contributed: 43
  • h-index: 15

Publications Top Notes

  • Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
    • Qi, F.-Z., Su, H.-S., Wang, B., …, Chen, Z.-N., Zhang, S.-H.
    • MedComm, 2024, 5(3), e512
  • Suicide gene delivery by morphology-adaptable enantiomeric peptide assemblies for combined ovarian cancer therapy
    • Song, N., Sun, Z., Wang, B., …, Zhang, S., Yu, Z.
    • Acta Biomaterialia, 2024, 175, pp. 250–261
  • Vesicle-mediated transport-related genes predict the prognosis and immune microenvironment in hepatocellular carcinoma
    • Ye, Z., Wang, Y., Yuan, R., …, Qian, L., Zhang, S.
    • Journal of Cancer, 2024, 15(12), pp. 3645–3662
  • Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma
    • Wang, B., Qi, F.-Z., Chen, P., …, Chen, Z.-S., Zhang, S.-H.
    • International Journal of Biological Sciences, 2024, 20(5), pp. 1634–1651
  • Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress
    • Sun, Z., Huang, J., Fishelson, Z., Wang, C., Zhang, S.
    • Biomedicines, 2023, 11(7), 1971
  • GRP75-driven, cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca2+ nanoparticles underlies distinct gene therapy effect in ovarian cancer
    • Su, L., Sun, Z., Qi, F., …, Chen, Z., Zhang, S.
    • Journal of Nanobiotechnology, 2022, 20(1), 340
  • Novel GIRlncRNA Signature for Predicting the Clinical Outcome and Therapeutic Response in NSCLC
    • Zhang, Q., Liu, X., Chen, Z., Zhang, S.
    • Frontiers in Pharmacology, 2022, 13, 937531

 

Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Published on by Academic Awards

Dr. Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Dr. Xintian Shao, Shandong First Medical University & Shandong Academy of Medical Sciences, China

Dr. Xintian Shao earned her PhD in Microbiology and Biochemical Pharmacy from Shandong University, China, under the guidance of Prof. Peixue Ling. She expanded her expertise as a Visiting Scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Currently serving as an Associate Professor at Shandong First Medical University, her research has yielded 10 impactful publications and secured numerous grants. With two patents to her name, she’s been honored with prestigious awards including the Shandong Medical Science and Technology Award and the Science and Technology Award of Shandong Pharmaceutical Association.

 

Publication Profile 

Scopus

Education and Academic Achievements 📚🏅

Dr. Xintian Shao completed her PhD in Microbiology and Biochemical Pharmacy at the School of Pharmacy, Shandong University, China, under the guidance of Prof. Peixue Ling. She further enriched her expertise as a visiting scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Her prolific research has resulted in 10 publications, including notable contributions to journals such as Advanced Drug Delivery Reviews and Advanced Science. With multiple patents and prestigious grants to her credit, she has earned recognition including the Shandong Medical Science and Technology Award (2021) and the Science and Technology Award of Shandong Pharmaceutical Association (2022).

Work Experience 💼

Dr. Xintian Shao has served as an Associate Professor at the School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, China. Her role involves not only teaching and mentorship but also continued research contributions in her field.

Research Focus

Dr. Xintian Shao’s research primarily focuses on subcellular imaging and targeted drug delivery systems. Her work delves into the intricate dynamics of organelle interactions, particularly within mitochondria and lysosomes, employing cutting-edge super-resolution imaging techniques. She explores novel methods for visualizing drug molecules within living organisms, enhancing our understanding of drug distribution and efficacy. With a keen interest in membrane biology and organelle-specific targeting, her contributions shed light on fundamental cellular processes and hold promise for advancements in drug delivery and therapeutics.

Publication Top Notes 

  1. “Single-organelle localization-based super-resolution imaging for subcellular molecules micro-dynamics” by Fang, G. et al., Coordination Chemistry Reviews, 2024.
  2. “Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms” by Sun, T. et al., Acta Pharmaceutica Sinica B, 2024.
  3. “Mitochondrial nucleoid condensates drive peripheral fission through high membrane curvature” by Chen, Q. et al., Cell Reports, 2023.
    Cited by: 1
  4. “Graphene Oxide Nanosheets Induce Mitochondrial Fragmentation by Cutting through Membrane” by Shao, X. et al., ACS Materials Letters, 2023.
    Cited by: 4
  5. “Subcellular visualization: Organelle-specific targeted drug delivery and discovery” by Shao, X. et al., Advanced Drug Delivery Reviews, 2023.
    Cited by: 7
  6. “Recent advances in fluorescent probes of peroxynitrite: Structural, strategies and biological applications” by Sun, J. et al., Theranostics, 2023.
    Cited by: 8
  7. “Single Image Capture of Bioactive Ion Crosstalk within Inter-Organelle Membrane Contacts at Nanometer Resolution” by Fang, G. et al., Small Methods, 2022.
    Cited by: 8
  8. “Lysosome-Targeted Biosensor for the Super-Resolution Imaging of Lysosome–Mitochondrion Interaction” by Wang, H. et al., Frontiers in Pharmacology, 2022.
    Cited by: 4
  9. “Super-resolution image-based tracking of drug distribution in mitochondria of a label-free naturally derived drug molecules” by Wei, Y. et al., Chemical Engineering Journal, 2022.
    Cited by: 19
  10. “Prefused lysosomes cluster on autophagosomes regulated by VAMP8” by Chen, Q. et al., Cell Death and Disease, 2021.
    Cited by: 24